Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation - Wikidata - wikimedia - TriplyDB

Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation

Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation

http://www.wikidata.org/entity/Q28254421

about

Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma Allogeneic stem cell transplantation versus conventional therapy for advanced primary cutaneous T-cell lymphoma Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphoma Advancement in high dose therapy and autologous stem cell rescue in lymphoma Consolidative autologous hematopoietic stem-cell transplantation in first remission for non-Hodgkin lymphoma: current indications and future perspective Treatment of peripheral T-cell lymphoma: are we data driven or driving the data?Oral fludarabine in combination with doxorubicin and dexamethasone as first-line therapy for nodal peripheral T-cell lymphomas: early results of a prospective multicenter study.Outcomes of related donor HLA-identical or HLA-haploidentical allogeneic blood or marrow transplantation for peripheral T cell lymphoma Recent advances on the molecular mechanisms involved in the drug resistance of cancer cells and novel targeting therapies Should eligible patients with T-cell lymphoma receive high-dose therapy and autologous stem cell transplant in the upfront setting?Brentuximab vedotin in the front-line treatment of patients with CD30+ peripheral T-cell lymphomas: results of a phase I study Long-term results of autologous hematopoietic cell transplantation for peripheral T cell lymphoma: the Stanford experience.Treatment of High-Risk T-NHL with Stem Cell Transplantation: A Single Center Experience.Autologous stem cell transplantation as the first-line treatment for peripheral T cell lymphoma: results of a comprehensive meta-analysis.Pathogenetic and diagnostic significance of microRNA deregulation in peripheral T-cell lymphoma not otherwise specified.Primary treatment response rather than front line stem cell transplantation is crucial for long term outcome of peripheral T-cell lymphomas.Comparison of survival in patients with T cell lymphoma after autologous and allogeneic stem cell transplantation as a frontline strategy or in relapsed disease.New developments in the treatment of peripheral T-cell lymphoma - role of Belinostat.How I treat the peripheral T-cell lymphomas Romidepsin for the Treatment of Peripheral T-Cell Lymphoma.How to predict the outcome in mature T and NK cell lymphoma by currently used prognostic models?High-dose therapy and autologous hematopoietic cell transplantation in peripheral T cell lymphoma (PTCL): analysis of prognostic factors.Consolidative treatment after salvage chemotherapy improves prognosis in patients with relapsed extranodal natural killer/T-cell lymphoma Autologous stem cell transplantation as consolidation therapy for patients with peripheral T cell lymphoma in first remission: long-term outcome and risk factors analysis.Hematopoietic stem cell transplantation in peripheral T-cell lymphomas.Targeting of cancer stem/progenitor cells plus stem cell-based therapies: the ultimate hope for treating and curing aggressive and recurrent cancers.Current Biosafety Considerations in Stem Cell Therapy.Efficacy of peripheral blood stem cell transplantation versus conventional chemotherapy on anaplastic large-cell lymphoma:a retrospective study of 64 patients from a single center.CHO(E)P-14 followed by alemtuzumab consolidation in untreated peripheral T cell lymphomas: final analysis of a prospective phase II trial.First-line therapy of peripheral T-cell lymphoma: extension and long-term follow-up of a study investigating the role of autologous stem cell transplantation.Strategies for relapsed peripheral T-cell lymphoma: the tail that wags the curve.Controversies in the treatment of lymphoma with autologous transplantation.Stem cell transplantation as a biological therapy for peripheral T-cell lymphomas.Transplantation for non-Hodgkin lymphoma.Guidelines for the management of mature T-cell and NK-cell neoplasms (excluding cutaneous T-cell lymphoma).Hematopoietic cell transplantation for lymphomas.Should patients with aggressive peripheral T-cell lymphoma all be treated the same?: no... well yes, ...but maybe not for long Novel therapies for peripheral T-cell lymphomas.Peripheral T-cell lymphomas: a review of current approaches and hopes for the future.Current state of art for transplantation paradigms in peripheral T-cell lymphomas.

P2860

Q24200183-D472AA0C-526D-4DA7-AD20-821470C8FD9F Q24203887-B0A6D759-482D-401F-BDEC-657D99214BA8 Q24633761-EFBC172E-5BB2-4C27-927F-D3061B442E81 Q26795538-5622D3DC-535F-421E-827E-BF8E6BF5877C Q26998446-883E5A11-5731-48B8-A9C8-6197687C3BC0 Q30613674-8F02CAD2-96E5-437E-A1DF-64AD16F14FA2 Q33396356-45A8091C-D5A6-45A5-8C9F-41AE30DC405C Q33608520-43687620-B8CE-4C31-984D-D99373276994 Q33730375-BF675CC7-C34C-4752-9285-D0C111CF0C2D Q33822764-22E11A2C-8235-48D2-923B-47D6FC585CDF Q34226010-F429BD53-DEC4-4124-8B1C-369AF70BC93E Q34307446-7F51D4BB-AD73-4732-B482-6C27BA1D52DC Q34766846-BDFE4837-A071-4ED0-B0C0-6987A904C722 Q35025993-097EC785-0EE3-43EF-9A6C-82B04B13172E Q35104047-F1619FAC-05EC-477C-8E08-50BB5C011373 Q35224833-73307ACB-9AE1-4208-A10E-2319D0DBB6EF Q35533531-377AE14D-4DA6-4816-89CD-B7A3189AB9C0 Q35703714-D2497C4E-F1D6-4318-B796-DB4C4E02A821 Q35865090-39BB6D37-8128-4DBF-9DBE-3BA903C3691F Q36064937-C20F1DEE-7423-4226-A805-D329F67B2AC9 Q36355093-9E9ED735-2255-43EA-A272-7CD2BD441DA7 Q36604739-C838A2C4-BD5D-4F7D-B699-4496671E8899 Q36760583-FE8BB9C8-2BAC-4DEC-8CA0-4EC9A20F4B9E Q36907048-8137C530-4ADD-415B-B16C-32BC6F9C5D66 Q36911495-4907D106-4E2E-48DB-8183-5C3C78A31A39 Q37144023-60CDE875-7A47-4B1D-A785-C6692D5783E2 Q37183239-9C75609C-034F-4785-BA68-A48BBB9B61F9 Q37183767-63DE4464-98F8-410E-B42C-6AA45A965F77 Q37214534-BEFCD214-EB77-4E11-A459-3045D9761726 Q37271019-6DCED225-9E21-4F96-883F-B57610B76CAD Q37391571-53612C03-DE6B-432E-97B3-E1A845C48A7B Q37593800-46FDEB4D-59CD-4848-A601-170B98671A08 Q37809085-334339F4-F568-4FF3-B9D6-BA623E43DC4F Q37810079-FC07BD05-18C7-4D28-BB44-E3A7D788038B Q37863688-435FD38D-2AB6-4FA0-B28D-AC01C214B293 Q37942817-3BEBFF45-9013-4EA5-8057-958493761B85 Q38046051-7406DD94-B9FD-4324-9CE7-44E3CCD01201 Q38111388-AB27787D-C1AE-4A0C-85DF-417515251361 Q38113568-4E341E82-DE97-45D9-8880-C3253C55DE74 Q38132821-A19BB9DA-D48A-41DC-97DE-FC621001F4DC

P2860

Long-term follow-up of patients with peripheral T-cell lymphomas treated up-front with high-dose chemotherapy followed by autologous stem cell transplantation

http://www.wikidata.org/entity/Q28254421

description

2006 nî lūn-bûn

@nan

2006 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2006 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2006年の論文

@ja

2006年論文

@yue

2006年論文

@zh-hant

2006年論文

@zh-hk

2006年論文

@zh-mo

2006年論文

@zh-tw

2006年论文

@wuu

name

Long-term follow-up of patient ...... gous stem cell transplantation

@ast

Long-term follow-up of patient ...... gous stem cell transplantation

@en

Long-term follow-up of patient ...... gous stem cell transplantation

@nl

type

label

Long-term follow-up of patient ...... gous stem cell transplantation

@ast

Long-term follow-up of patient ...... gous stem cell transplantation

@en

Long-term follow-up of patient ...... gous stem cell transplantation

@nl

prefLabel

Long-term follow-up of patient ...... gous stem cell transplantation

@ast

Long-term follow-up of patient ...... gous stem cell transplantation

@en

Long-term follow-up of patient ...... gous stem cell transplantation

@nl

P1433

Q28254421-029D6C4D-249E-44BF-A1D4-DEDFCF864647

P1476

Q28254421-616A6C6D-169C-4620-839C-80E0486597D9

P2093

Q28254421-04AC8C9B-DE95-4B25-974A-4FDCE19864A1

Q28254421-0DC553E9-4B44-4906-8AC4-9A7966E8D31A

Q28254421-26EB9E7E-7DE8-4473-8C11-6779B9440C76

Q28254421-2CC49F97-A44D-4828-8773-B3D3F34AFC9D

Q28254421-4F15449F-DF2F-41C9-9844-046E765BB777

Q28254421-B25F9BB0-5D0F-49EE-B44F-0A3C8CC6B5B3

Q28254421-C7848E56-476F-4300-9D7C-FC705B515454

Q28254421-D10359CE-9DD4-4319-A869-868D1558DD38

Q28254421-E2AAF5BF-61AA-43B0-818A-3DAB0D8F63AC

Q28254421-FFF39F08-EB05-45A0-A3EB-FEB27000DC9B

P2860

Q28254421-12C7EFFD-A4A0-47B0-A88D-B11F80DE102E

Q28254421-1392D2EC-A422-4587-BEBA-162274938DE8

Q28254421-21EABCE9-8D29-4ECF-B34E-066DCAB63E92

Q28254421-39754F81-CA04-40A1-BF63-BF384175C896

Q28254421-449D8772-1755-4B4F-AC08-DEC5A5014A21

Q28254421-56296D30-BF63-4E10-95EB-A0315EBB4569

Q28254421-5CE12C0A-36A2-4F22-8228-0F1843E4CB5B

Q28254421-5F18A650-8D13-46B6-B086-8EF589B6ADB3

Q28254421-6491D88B-2EB1-4B63-A174-A73D5FD66B69

Q28254421-84277D9C-EAAB-4084-8214-B399EDDD3722

P2888

Q28254421-6E46A83B-ED24-44ED-9861-E591FC3FBAA9

P304

Q28254421-8A63698B-3D28-4EC2-A7FF-36539E0084B9

P31

Q28254421-8AEF227A-4082-4149-B938-32E6B94E4EA2

P3181

Q28254421-DD882AF4-4287-49A9-8ABB-54FE7693B92B

P356

Q28254421-9BD3E6F2-3960-47BD-9B8A-D0B08DBEFB37

P407

Q28254421-92CA0A78-E6FC-4A36-9B3F-AA847D3C599C

P433

Q28254421-9E20F215-C6FF-478C-9A25-3E826B7781FE

P478

Q28254421-A34B9576-5F0E-4208-94B9-F2B20A7DE971

P577

Q28254421-00671A6C-31AB-4C44-BE20-80F4A539E042

P5875

Q28254421-AFA77E3B-825F-4C4E-8C86-67A7CFCF5136

P6179

Q28254421-7BEE4FE4-7773-4BA3-99E7-1CECCA521D62

P698

Q28254421-47787D16-17B1-48CB-811B-1DA9CED2A747

P921

Q28254421-3056BF80-2C49-41FC-9B23-1BCF10D76559

Q28254421-BE04168C-9AE9-44F9-ADB9-A7FB078F130F

P3181

P356

P1433

P1476

Long-term follow-up of patient ...... gous stem cell transplantation

@en

P2093

A Dodero

http://www.w3.org/2001/XMLSchema#string

A M Gianni

http://www.w3.org/2001/XMLSchema#string

A Rambaldi

http://www.w3.org/2001/XMLSchema#string

C Tarella

http://www.w3.org/2001/XMLSchema#string

F Zallio

http://www.w3.org/2001/XMLSchema#string

M Zanni

http://www.w3.org/2001/XMLSchema#string

P Corradini

http://www.w3.org/2001/XMLSchema#string

P Valagussa

http://www.w3.org/2001/XMLSchema#string

S Cortelazzo

http://www.w3.org/2001/XMLSchema#string

T Barbui

http://www.w3.org/2001/XMLSchema#string

P2860

Nonparametric Estimation from Incomplete Observations

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Survival benefit of high-dose therapy in poor-risk aggressive non-Hodgkin's lymphoma: final analysis of the prospective LNH87-2 protocol--a groupe d'Etude des lymphomes de l'Adulte study.

Shortened first-line high-dose chemotherapy for patients with poor-prognosis aggressive lymphoma.

Autologous stem cell transplantation in adult patients with peripheral T-cell lymphoma: a nation-wide survey.

High-dose therapy with autologous stem cell transplantation in patients with peripheral T cell lymphomas.

Intensification of salvage treatment with high-dose sequential chemotherapy improves the outcome of patients with refractory or relapsed aggressive non-Hodgkin's lymphoma.

Impact of high-dose chemotherapy on peripheral T-cell lymphomas.

High-dose ara-C with autologous peripheral blood progenitor cell support induces a marked progenitor cell mobilization: an indication for patients at risk for low mobilization.

Autologous stem cell transplant for relapsed and refractory peripheral T-cell lymphoma: variable outcome according to pathological subtype.

P2888

P304

1533-8

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2503375

http://www.w3.org/2001/XMLSchema#string

P356

10.1038/SJ.LEU.2404306

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

20

http://www.w3.org/2001/XMLSchema#string

P577

2006-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6915696

http://www.w3.org/2001/XMLSchema#string

P6179

1020476651

http://www.w3.org/2001/XMLSchema#string

P698

16871285

http://www.w3.org/2001/XMLSchema#string

P921